• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …

Background Patients with stable coronary artery disease and diabetes mellitus who have not
had a myocardial infarction or stroke are at high risk for cardiovascular events. Whether …

Background: Ezetimibe, when added to simvastatin, reduces cardiovascular events after
acute coronary syndrome. We explored outcomes stratified by diabetes mellitus (DM) …

ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …

The recommendations listed in this CPG are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2012, and other selected …

comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Background Patients with stable coronary artery disease and diabetes with previous
percutaneous coronary intervention (PCI), particularly those with previous stenting, are at …